ACH
LAB icon

ArrowMark Colorado Holdings’s Standard BioTools LAB Stock Holding History

ArrowMark Colorado Holdings’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-27,572
Closed -$1.16M – 304
2015
Q1 		$1.16M Sell
27,572
-6,905
-20% -$273K 0.03% 222
2014
Q4 		$1.16M Buy
+34,477
New +$976K 0.03% 208

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

ArrowMark Colorado Holdings's LAB Position: Q2 2015 in Review

ArrowMark Colorado Holdings sold out of Standard BioTools (LAB) in Q2 2015, closing a stake of 27,572 shares — an estimated $1.16M sold.

ArrowMark Colorado Holdings first reported a position in LAB in Q4 2014 and held it in 2 quarters. The position peaked at $1.16M in Q4 2014. 107 funds tracked by Wall St. Rank hold LAB as of Q2 2015.

  • ArrowMark Colorado Holdings reported no remaining Standard BioTools position as of Q2 2015 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 27,572 Standard BioTools shares in Q2 2015, an estimated $1.16M.
  • ArrowMark Colorado Holdings first reported a position in Standard BioTools in Q4 2014 and held it in 2 quarters.
  • ArrowMark Colorado Holdings's Standard BioTools position peaked at $1.16M in Q4 2014.
  • 107 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2015.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2015, filed 14 Aug 2015.